A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder.

Hobart, Mary; Zhang, Peter; Skuban, Aleksandar; Brewer, Claudette; Hefting, Nanco; Sanchez, Raymond; McQuade, Robert D

Hobart, Mary; Zhang, Peter; Skuban, Aleksandar; Brewer, Claudette; Hefting, Nanco; Sanchez, Raymond; McQuade, Robert D.

Affiliation

Hefting N; H. Lundbeck A/S, Valby, Denmark.

J Clin Psychopharmacol ; 39(3): 203-209, 2019.

Article in En | MEDLINE | ID: mdl-30946704

Subject(s)

Antidepressive Agents/administration & dosage; Depressive Disorder, Major/drug therapy; Quinolones/administration & dosage; Thiophenes/administration & dosage; Adult; Antidepressive Agents/adverse effects; Dopamine Agonists/administration & dosage; Dopamine Agonists/adverse effects; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinolones/adverse effects; Serotonin Agents/administration & dosage; Serotonin Agents/adverse effects; Thiophenes/adverse effects; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Quinolones / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychopharmacol Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google